In order to help enterprises better understand the filing status of health food (dietary supplements) in China, CIRS has gathered statistics on health foods approved in 2026 (as of June 30) and analyzed them from multiple perspectives.

GACC Decree No. 280 was promulgated on October 14, 2025, and officially entered into force on June 1, 2026.

With the first half of 2026 concluded, Chinese ingredient companies are demonstrating strong momentum in GRAS notices; the number of approvals secured in this period alone (16) rivals the total for the entire year of 2025 (19). Drawing on publicly available FDA GRAS notice data, CIRS Group has compiled updates from January to June. By systematically reviewing metrics such as total volume, ingredient categories, outcomes, and the origins of applicants, CIRS provides valuable insights for food ingredient companies looking to enter the U.S. market.

According to the information released by the Center for Food Evaluation of the State Administration for Market Regulation and the Special Food Information Query Platform, a total of 1136 health food registration approvals were issued in the first half of 2026. Among these, 121 were for new health food products, including 3 imported products.

The State Administration for Market Regulation has revised and drafted the Detailed Rules for the Review of Production Licensing for Infant and Young Child Complementary Foods (Draft for Comment) and is now soliciting public opinion. The deadline for submitting comments is August 1, 2026.

The EFSA Panel on Food Contact Materials (FCM) assessed the safety of the Bandera Twin recycling process (EU register number RECYC341).

China’s SAMR has released Q&As on the implementation of the Administrative Measures for the Supervision and Administration of Entrusted Food Production (hereinafter referred to as the "Measures"), further clarifying the requirements for entrusted food production. Notably, the production of health foods cannot be outsourced in stages (split-stage production). The Measures will take effect on December 1, 2026; enterprises should prepare for compliance in advance.

Recently, S-adenosyl-L-methionine disulfate tosylate (SAMe-DT), independently developed by Shandong Freda Biotechnology Co., Ltd. (hereinafter refered to as Shandong Freda), has successfully completed FDA New Dietary Ingredient (NDI) notification, with the NDIN number being 1473, marking the ingredient’s compliance for entry into the U.S. dietary supplement market. CIRS Group provided full support throughout the notification process.

China’s list of new food ingredients with terminated reviews has been updated to include tuna carnosine concentrate, Mycoprotein from Fusarium venenatum, and banana flower. To date, a total of 102 substances have been included in the terminated review list.

The food enzyme dextransucrase (sucrose:1,6-α-d-glucan 6-α-d-glucosyltransferase; EC 2.4.1.5) is produced with the genetically modified Bacillus subtilis strain DP-Eyp97 by Genencor International B.V. The production strain met the requirements for the qualified presumption of safety. The food enzyme was considered free from viable cells of the production organism and its DNA.